Description
Technical Parameters
Product Brief Introduction
Product name: Bevacizumab
CAS: 216974-75-3
MF: C14H18ILiN2O3
MW: 396.15
Product Specification
|
Appearance |
Light-brown to colorless liquid |
|
Isoelectric Point |
Meet the standards |
|
Concentration |
22.5 ~ 27.5mg/ml |
|
Non-Reduced CE-SDS |
Main peak≥90.0% |
|
SEC (HPLC) |
Main peak≥95.0% |
|
Residual Proteins of Host Cell |
≤100ng/mg |
|
Exogenous Residual DNA |
≤100pg/mg |
|
Residual Protein A |
≤100ng/mg |
|
Biological Activity |
80.0% ~ 125.0% |
|
Osmolality |
Meet the standards |
|
Peptide Mapping |
Meet the standards |
|
Bacterial Endotoxins |
≤3EU/mg |
|
N-Terminal Sequence |
Meet the standards |



